| Session 1: Sexually transmitted infections | ||
| STIs – trends and epidemiology | M. van de Laar (The Netherlands) | Abstract |
| User issues/holistic model | J. Adams (UK) | |
| Integrated sexual health services | P. Greenhouse (UK) | Abstract |
|
||
| Session 2: Appropriate screening in sexual health | ||
| Should we screen? | P. Greenhouse (UK) | |
| Opportunistic screening for Chlamydia trachomatis: establishing the national chlamydia screening programme in England | D.S. LaMontagne (UK) | Abstract |
| Ethics/psychology | S.V. Carr (UK) | Abstract |
|
|
||
| Session 3: Non-contraceptive effects | ||
| Polycystic ovary syndrome | D. Cibula (Czech Republic) | |
| Hormonal contraceptives for the medical treatment of endometriosis | G. Crosignani (Italy) | Abstract |
| Health benefits – breast and bone | A. Glasier (UK) | Abstract |
| Non-contraceptive effects – dysfunctional uterine bleeding | I. Milssom (Sweden) | Abstract |
|
|
||
| Session 4: Abortion | ||
| Abortion methods: European issues | C. Fiala (Austria) | Abstract |
| Home administration | Ph. Lefebvre (France) | |
| Ethical and global aspects of abortion | H. Goldstein (Denmark) | Abstract |
| Abortion; Influencing politics | M.M. Lech (Poland) | Abstract |
|
|
||
| Session 5: Risks, the individual perspective | ||
| Determinants of sexual and reproductive behaviour | R.H.W. van Lunsen (The Netherlands) | Abstract |
| Individual risk perception in STI prevention | N. Bajos (France) | Abstract |
| Risk and unwanted pregnancy | O. Graham (UK) | |
|
|
||
| Session 6: Risk communication | ||
| How do we measure risks in epidemiological terms? | T. Farley (WHO, Switzerland) | Abstract |
| How do we communicate risk? | A. Herxheimer (UK) | Abstract |
| Coping with scares | H.P.G. Schneider (Germany) | Abstract |
|
|
||
| Session 7: Male and female steroidal contraception | ||
| New developments | S. Skouby (Denmark) | |
| New progestins | R. Sitruk-Ware (France) | Abstract |
| Male steroidal contraception | R.A. Andersen (UK) | Abstract |
|
|